Douglas A Treco Inozyme Pharma, Inc. (INZY) insider trading activity
Douglas A Treco is CEO of Inozyme Pharma, Inc.. Currently has a direct ownership of 20,665 shares of INZY, which is worth approximately $99,605. The most recent transaction as insider was on Apr 02, 2024, when has been sold 7,523 shares (Common Stock) at a price of $6.94 per share, resulting in proceeds of $52,209. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
20.7K
n/a
3M change
n/a
12M change
Total Value Held
$99,605
Douglas A Treco Transaction History
Also insider at
DAT
Douglas A Treco
CEO
Cambridge, MA